Patients with non-Hodgkin's lymphoma receiving myelosuppressive chemotherapy with first and subsequent cycle pegfilgrastim support experience low rates of neutropenic complications: Preliminary results of FIRST, a prospective community-based study.

被引：0
|
作者：
Ozer, H
Noga, SJ
Morrison, VA
Ding, BY
Dansey, R
机构：
[1] Univ Oklahoma, Ctr Canc, Oklahoma City, OK USA
[2] Alvin & Lois Lapidus Canc Inst, Baltimore, MD USA
[3] Vet Affairs Med Ctr, Minneapolis, MN USA
[4] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.4705.4705
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4705
引用
收藏
页码：256B / 256B
页数：1
相关论文
共 18 条
  • [1] Impact of 1st and subsequent cycle pegfilgrastim on neutropenic events in patients receiving myelosuppressive chemotherapy:: Preliminary results of FIRST, a prospective community-based study
    Ozer, H
    Mirtsching, B
    Rader, M
    Ding, B
    Dansey, R
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 758S - 758S
  • [2] First and subsequent cycle pegfilgrastim results in low rates of neutropenic events in patients receiving myelosuppressive chemotherapy.
    Rader, ME
    Breyer, W
    Luedke, S
    Truscinski, D
    Ding, B
    Dansey, R
    Ozer, H
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S215 - S216
  • [3] Final results of a large, community-based, prospective study evaluating the impact of first and subsequent cycle pegfilgrastim on neutropenic events in patients receiving myelosuppressive chemotherapy.
    Ozer, H.
    Mirtsching, B.
    Rader, M.
    Ding, B.
    Truscinski, D.
    Dreiling, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 485S - 485S
  • [4] Low incidence of neutropenic events in patients with lymphoma receiving first-cycle pegfilgrastim with chemodierapy: Results from a prospective community-based study
    Noga, Stephen J.
    Choksi, Janak K.
    Ding, Beiying
    Dreiling, Lyndah
    Ozer, Howard
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 (06): : 413 - 420
  • [5] Final results of a large, community based, prospective study evaluating the impact of first and subsequent cycle pegfilgrastim on neutropenic events.
    Rader, M.
    Ding, B.
    Dreiling, L.
    Ozer, H.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S283 - S283
  • [6] SECONDARY IMMUNODEFICIENCY IN PATIENTS WITH NON-HODGKIN LYMPHOMA (NHL): OBSERVATIONAL, DESCRIPTIVE, UNICENTRIC STUDY. Results: PRELIMINARY OF THE FIRST 52 PATIENTS
    Cabrera Ruiz, F. J.
    Garcia Sanchez, R.
    Castillo Bazan, E.
    Llamas Sillero, P.
    Cordoba Mascunano, R.
    HAEMATOLOGICA, 2019, 104 : 378 - 379
  • [7] Final results of a large, community based study evaluating the impact of first and subsequent cycle pegfilgrastim on neutropenic events in NHL and HD patients.
    Noga, Stephen J.
    Choksi, Janak
    Ding, Beiying
    Dreiling, Lyndah
    Ozer, Howard
    BLOOD, 2006, 108 (11) : 341A - 341A
  • [8] Febrile neutropenia (FN) and pegfilgrastim prophylaxis in breast cancer and non-Hodgkin’s lymphoma patients receiving high (> 20%) FN-risk chemotherapy: results from a prospective observational study
    Jean Paul Salmon
    Martin Smakal
    Charisios Karanikiotis
    Marek Z. Wojtukiewicz
    Yohann Omnes
    Lucy DeCosta
    Sally Wetten
    James O’Kelly
    Supportive Care in Cancer, 2019, 27 : 1449 - 1457
  • [9] FIRST-LINE CHEMOTHERAPY LEADS TO HIGH BONE TURNOVER AND REDUCED BONE MASS IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA: RESULTS FROM A PROSPECTIVE STUDY
    Anargyrou, K.
    Vassilakopoulos, T.
    Tsionos, K.
    Kokkoris, P.
    Boutsikas, G.
    Angelopoulou, M.
    Christoulas, D.
    Masouridou, S.
    Dimou, M.
    Papatheodorou, A.
    Chatzifotiadis, D.
    Panayiotidis, P.
    Pangalis, G.
    Beris, P.
    Terpos, E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 370 - 370
  • [10] Time to first neutropenia hospitalization during first course chemotherapy among newly diagnosed non-Hodgkin's lymphoma patients: National SEER-medicare study.
    Voelker, MD
    Rubenstein, LM
    Chrischilles, EA
    Chen-Hardee, SS
    Link, BK
    Wright, KB
    Brooks, JM
    Delgado, DJ
    BLOOD, 2003, 102 (11) : 253A - 253A
12